Sanofi (SNY) Non-Current Deferred Tax Liability (2009 - 2025)

Sanofi (SNY) has 17 years of Non-Current Deferred Tax Liability data on file, last reported at $1.9 billion in Q4 2025.

• Quarterly Non-Current Deferred Tax Liability fell 16.21% year-over-year to $1.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 billion (down 16.21% YoY) and the FY2025 annual result came in at $1.9 billion, down 16.21% from the prior year.
• Non-Current Deferred Tax Liability steadied at $1.9 billion in Q4 2025 per SNY's latest filing, from $1.9 billion in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $2.3 billion in Q4 2024, with the low at $1.7 billion in Q2 2022.
• Average Non-Current Deferred Tax Liability over 5 years is $2.0 billion, with a median of $1.9 billion recorded in 2025.
• Year-over-year, Non-Current Deferred Tax Liability fell 17.96% in 2022 and advanced 28.38% in 2023.
• Sanofi's Non-Current Deferred Tax Liability stood at $1.8 billion in 2021, then climbed by 1.54% to $1.9 billion in 2022, then climbed by 6.38% to $2.0 billion in 2023, then rose by 15.84% to $2.3 billion in 2024, then retreated by 16.21% to $1.9 billion in 2025.
• Business Quant data shows SNY's Non-Current Deferred Tax Liability at $1.9 billion in Q4 2025, $1.9 billion in Q2 2025, and $2.3 billion in Q4 2024.